Immortality forever!
Cancer kills when it goes metastatic. Pieces of a primary tumor fly around in the body and start up lots of other tumors. If you could stop the pieces from flying around you could cure 80 percent of cancers. Cells are held together by things like the adherens junction. There is only one way to observe their dynamics, neutron spin echo spectroscopy. My laboratory is the only one in the world that can do that.
#longevity #futureofmedicine #biotechnology #healthtech #scicomm
#mindblowing #didyouknow
Understanding cancer metastasis is key to improving survival rates, as metastasis accounts for the majority of cancer-related deaths. When cancer cells detach from a primary tumor and spread, they form new tumors in other body parts, making treatment much more challenging. A critical factor in this process involves the breakdown of cell adhesion structures, such as the adherens junction, which normally help keep cells tightly bound together. One pioneering approach to studying these microscopic interactions involves neutron spin echo spectroscopy (NSE). This advanced technique allows scientists to observe the dynamics of protein nanomachines and cellular junctions at unprecedented resolution. By capturing how these adhesive proteins function and fail, researchers can identify new ways to prevent tumor cells from breaking away and spreading. The exclusive use of NSE by a limited number of labs worldwide underscores its importance and complexity. With this technology, scientists can better understand how tumors metastasize on a molecular level, which opens new avenues for therapies aimed at strengthening cell adhesion or targeting the mobile tumor fragments before they establish secondary growths. Moreover, recent developments in robotics and nanotechnology, as highlighted by concepts of robots building smaller robots and protein nanomachines, hint at future medical interventions where microscopic devices may be deployed to repair or reinforce cellular structures. This intersection of biotechnology and healthtech could one day eliminate metastatic cancer as a cause of death, moving us closer to the dream of extended healthspan and potentially, immortality. For anyone fascinated by longevity and the future of medicine, this field represents a thrilling frontier. By combining disciplines—neutron spectroscopy, molecular biology, robotics, and biotechnology—we are beginning to rewrite the rules of disease and aging. Continual advances and collaboration across these sectors hold incredible promise for turning life-threatening diseases into manageable or curable conditions, offering hope for a healthier, longer life.
